APT Medical Inc. (SHA:688617)

Market Cap	41.03B
Revenue (ttm)	2.17B
Net Income (ttm)	716.16M
Shares Out	141.01M
EPS (ttm)	5.08
PE Ratio	57.33
Forward PE	45.93
Dividend	1.21 (0.41%)
Ex-Dividend Date	Jun 19, 2025

Volume	1,126,462
Average Volume	1,019,240
Open	297.00
Previous Close	296.93
Day's Range	288.20 - 298.80
52-Week Range	215.92 - 331.03
Beta	-0.32
RSI	52.08
Earnings Date	Aug 22, 2025

About APT Medical

APT Medical Inc. engages in the research, development, manufacturing, and supply of electrophysiology and vascular interventional medical devices in China. The company offers electrophysiological products comprising mapping catheters, ablation catheters, transseptal needle and sheaths, and steerable sheaths; and interventional cardiology and peripheral intervention products, such as introducer kits, guiding extension catheters, balloon catheters, guiding catheters, microcatheters, guidewires, hydrophilic angiographic catheters, hydrophilic guid...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2002
• Employees: 2,555
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688617

Financial Performance

In 2024, APT Medical's revenue was 2.07 billion, an increase of 25.18% compared to the previous year's 1.65 billion. Earnings were 673.15 million, an increase of 26.08%.